Trends in prescription days and intervals between physician visits and their impact on glycemic control before and during the COVID-19 pandemic in Japan-Reference-Cited by-同舟云学术

Trends in prescription days and intervals between physician visits and their impact on glycemic control before and during the COVID-19 pandemic in Japan

Published:2024-07-26 Issue:1 Volume:4 Page:18-22
ISSN:2436-293X
Container-title:GHM Open
language:en
Short-container-title:GHM Open

Author:

Yagome Susumu¹²,Ohsugi Mitsuru³⁴,Sugiyama Takehiro³⁵,Bouchi Ryotaro³⁴,Goto Atsushi¹⁶,Ueki Kohjiro³⁷

Affiliation:

1. Department of Health Data Science, Yokohama City University Graduate School of Data Science, Yokohama, Japan.

2. Integrity Healthcare Co., Ltd., Tokyo, Japan.

3. Diabetes and Metabolism Information Center, National Center for Global Health and Medicine, Tokyo, Japan.

4. Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine, Tokyo, Japan.

5. Department of Health Services Research, University of Tsukuba, Ibaraki, Japan.

6. Department of Public Health, School of Medicine, Yokohama City University, Yokohama, Japan.

7. Diabetes Research Centre, National Center for Global Health and Medicine, Tokyo, Japan.

Publisher

National Center for Global Health and Medicine (JST)

Link

https://www.jstage.jst.go.jp/article/ghmo/4/1/4_2023.01014/_pdf

Reference13 articles.

1. 1. Peric S, Stulnig TM. Diabetes and COVID-19 : Disease-management-people. Wien Klin Wochenschr. 2020; 132:356-361.

2. 2. National Institute of Health and Nutrition. Health Japan 21 (the second term). https://www.nibiohn.go.jp/eiken/kenkounippon21/en/index.html (accessed February 2, 2024).

3. 3. World Health Organization. COVID-19 significantly impacts health services for noncommunicable diseases. https://www.who.int/news/item/01-06-2020-covid-19-significantly-impacts-health-services-for-noncommunicable-diseases (accessed February 2, 2024).

4. 4. Ikesu R, Miyawaki A, Sugiyama T, Nakamura M, Ninomiya H, Kobayashi Y. Trends in diabetes care during the COVID-19 outbreak in Japan: An observational study. J Gen Intern Med. 2021; 36:1460-1462.

5. 5. Tanaka N, Hamamoto Y, Kurotobi Y, Yamasaki Y, Nakatani S, Matsubara M, Haraguchi T, Yamaguchi Y, Izumi K, Fujita Y, Kuwata H, Hyo T, Yamada Y, Kurose T, Seino Y. Lifestyle changes as a result of COVID-19 containment measures: Bodyweight and glycemic control in patients with diabetes in the Japanese declaration of a state of emergency. J Diabetes Investig. 2021; 12:1718-1722.